Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, May 08, 2026 (GLOBE NEWSWIRE) -- Hagens Berman, a global shareholder rights law firm, updates investors in ODDITY Tech Ltd. (NASDAQ: ODD) regarding the pending securities class action...
-
SOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that Merit...
-
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
-
Datasite acquires Valu8, a leading leading Swedish private market intelligence platform specializing in proprietary European company financial data
-
BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May...
-
IRVINE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: ...
-
Kodiak Driver deployed in eight additional fully-driverless trucks, for a total of 28 Customer-Owned Driverless Vehicles at the end of Q1Kodiak Driver-powered trucks accumulated more than 23,500 hours...
-
–Generated $29.4 Million in Cash Flow from Operations––Reaffirmed Full Year 2026 Net Revenue and Adjusted EBITDA Guidance– SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- Turtle Beach Corporation...
-
FDA approved AVLAYAH™ (tividenofusp alfa-eknm) for treatment of Hunter syndrome (MPS II) and as first medicine to leverage transferrin receptor to cross blood-brain barrierAVLAYAH launched in U.S....
-
Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026Five additional Phase 3 studies of azetukalner continue to enroll in...